Treating Adolescents and Young Adults (AYA) with Blood Cancer
Recorded October 11, 2023
Recorded on: October 11, 2023
1.0 CME Credit for physicians available until: June 11, 2025
1.0 CE Contact hour for nurses and social workers available until: June 11, 2025
1.0 CE Contact hour for nurse practitioners available until: December 31, 2024
Format: Non-interactive recorded webinar
Target Audience
This activity is intended for hematologist/oncologists, nurses, social workers, and other healthcare professionals involved in the care of patients with blood cancer.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe blood cancers common in adolescent and young adults (AYAs)
- Identify signs and symptoms of common blood cancers in AYAs and diagnostic tests used
- Explain treatment options, including new and emerging data and the role of clinical trials
- Discuss the management of short and long-term effects, as well as unique considerations for AYAs
- List resources to support patients and their caregivers
Faculty
Julie Anna Wolfson, MD, MSHS
Associate Professor, Pediatric Hematology-Oncology
Institute for Cancer Outcomes and Survivorship
Director, AYA Oncology and Oncofertility Program
University of Alabama at Birmingham
Birmingham, AL
Sharon M. Castellino, MD, MSc
Professor, Department of Pediatrics
Emory University School of Medicine
Director, Leukemia and Lymphoma Program
Aflac Cancer and Blood Disorders Center
Children's Healthcare of Atlanta
Atlanta, GA
Continuing Education Information
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
Social Worker Continuing Education
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.0 clinical continuing education credit.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.0 clinical CE contact hour for this activity.
Nurse Practitioner Continuing Education
This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.25 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23116459. This activity was planned in accordance with AANP Accreditation Standards and Policies.
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
There is no commercial support associated with this CE activity.
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc.
There is no commercial support associated with this CE activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.